Trial Outcomes & Findings for Effects of Prefeeding Oral Stimulation on Feeding Performance in Preterm Infants (NCT NCT01649362)
NCT ID: NCT01649362
Last Updated: 2014-03-12
Results Overview
transition period was defined as the period from the introduction of enteral feeding to full enteral feeding
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
101 participants
Primary outcome timeframe
participants were followed from date of randomization until full enteral feeding was acquired,an expected average of 5 weeks
Results posted on
2014-03-12
Participant Flow
Participant milestones
| Measure |
Control Group
no prefeeding oral stimulation
|
Oral Stimulation
preterm infants receiving an prefeeding oral stimulation program
|
|---|---|---|
|
Overall Study
STARTED
|
47
|
54
|
|
Overall Study
COMPLETED
|
46
|
40
|
|
Overall Study
NOT COMPLETED
|
1
|
14
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Effects of Prefeeding Oral Stimulation on Feeding Performance in Preterm Infants
Baseline characteristics by cohort
| Measure |
Control Group
n=46 Participants
no prefeeding oral stimulation
|
Oral Stimulation
n=40 Participants
preterm infants receiving an prefeeding oral stimulation program
|
Total
n=86 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
46 Participants
n=5 Participants
|
40 Participants
n=7 Participants
|
86 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Customized
|
31.3 weeks' gestational age
STANDARD_DEVIATION 1.7 • n=5 Participants
|
31.4 weeks' gestational age
STANDARD_DEVIATION 1.5 • n=7 Participants
|
31.3 weeks' gestational age
STANDARD_DEVIATION 1.6 • n=5 Participants
|
|
Sex: Female, Male
Female
|
21 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
36 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
25 Participants
n=5 Participants
|
25 Participants
n=7 Participants
|
50 Participants
n=5 Participants
|
|
Region of Enrollment
Luxembourg
|
46 participants
n=5 Participants
|
40 participants
n=7 Participants
|
86 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: participants were followed from date of randomization until full enteral feeding was acquired,an expected average of 5 weekstransition period was defined as the period from the introduction of enteral feeding to full enteral feeding
Outcome measures
| Measure |
Control Group
n=46 Participants
no prefeeding oral stimulation
|
Oral Stimulation
n=40 Participants
preterm infants receiving an prefeeding oral stimulation program
|
|---|---|---|
|
Length of Transition Period
|
16.0 days
Standard Deviation 6.9
|
16.9 days
Standard Deviation 9.2
|
SECONDARY outcome
Timeframe: participants were followed for the duration of hospital stay, an expected average of 5 weeksOutcome measures
| Measure |
Control Group
n=46 Participants
no prefeeding oral stimulation
|
Oral Stimulation
n=40 Participants
preterm infants receiving an prefeeding oral stimulation program
|
|---|---|---|
|
Length of Hospital Stay
|
42.5 days
Standard Deviation 15.1
|
45.7 days
Standard Deviation 16.8
|
SECONDARY outcome
Timeframe: hospital discharge, an expected average of 5 weeks from the beginning of oral feeding introductionOutcome measures
| Measure |
Control Group
n=46 Participants
no prefeeding oral stimulation
|
Oral Stimulation
n=40 Participants
preterm infants receiving an prefeeding oral stimulation program
|
|---|---|---|
|
Breastfeeding Rate at Discharge
|
21 participants
|
28 participants
|
Adverse Events
Control Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Oral Stimulation
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place